David Arkowitz, CFO and Chief Business Officer at AMAG PHARMACEUTICALS INC. (AMAG), bought 1,550 shares at $40.37 ($32K) on 2007-05-05, disclosed to the SEC on 2008-05-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 750 | $0 | 0.0% |
| 2 | $40.37 | 100 | $4K | 12.5% |
| 3 | $40.37 | 200 | $8K | 25.0% |
| 4 | $40.38 | 100 | $4K | 12.5% |
| 5 | $40.38 | 300 | $12K | 37.5% |
| 6 | $40.39 | 100 |
| $4K |
| 12.5% |
| Total | $20.84 avg | 1,550 | $32K | 100% |
| Filing → |
| MCRB | SELL | 2023-10-31 | $5K | — | Filing → |
| FLXN | SELL | 2021-05-12 | $16K | — | Filing → |
| FLXN | SELL | 2021-01-07 | $135K | — | Filing → |